Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Oct 23, 2020 11:07am

102 Views

Post# 31770732

S7, e1 & BT in action... like SVA ;)

Firstly, Superdriller Bond (S7), BioTeck has a talent that few can equal. It's called jerking your chain effectively to get a response... any response will do. My hat is off to him.

Regarding his hypothesis of having Sernova promote both hemophilia and thyroid vs insulin dependent diabetes... The present FDA trial data that we've had a glimpse of speaks for itself. Over 18 months in, COVID-19 on the prowl, candidates on immunosuppression AND the results are stellar AND the trial continues! The Pouch is able to tackle the most difficult and widespread problem. Think how it would banish the hemophilia and thyroid issues... Hasta La Vista Baby to them both.

elgin1 is arguably the most balanced poster on the Stockhouse V.SVA BB... nothing but the facts ma'am and in an easy to understand wording, thankfully he is here!

If BioTeck were totally at odds with Sernova's thrust of using the pouch for treating diabetes first, he would jerk everyone's chain differently, but he doesn't. In a moment of clarity he even backhand compliments the Pouch, i.e. he has some faith that it will all turn out AOK.

We need to remember (and here I am guilty of being too optimistic) that we are all trying to describe a purportedly winner medical device company with other bullets in its medical arsenal with not that much information. That said, the glimpses we do get allude to something that works that is totally disruptive for human medical kind. Now, if Big Pharma could somehow be privy to the real data... AND some institutions take a position... fireworks... come to think of it Guy Fawkes day (5 November) is coming soon!